333 related articles for article (PubMed ID: 19604259)
1. Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.
Levesque MC
Clin Exp Immunol; 2009 Aug; 157(2):198-208. PubMed ID: 19604259
[TBL] [Abstract][Full Text] [Related]
2. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
Tanaka Y
Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
[TBL] [Abstract][Full Text] [Related]
3. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
4. The potential utility of B cell-directed biologic therapy in autoimmune diseases.
Arkfeld DG
Rheumatol Int; 2008 Jan; 28(3):205-15. PubMed ID: 17957371
[TBL] [Abstract][Full Text] [Related]
5. B-cell-directed therapies for autoimmune disease.
Dörner T; Radbruch A; Burmester GR
Nat Rev Rheumatol; 2009 Aug; 5(8):433-41. PubMed ID: 19581902
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in treatment-resistant autoimmune blistering skin disorders.
Schmidt E; Bröcker EB; Goebeler M
Clin Rev Allergy Immunol; 2008 Feb; 34(1):56-64. PubMed ID: 18270859
[TBL] [Abstract][Full Text] [Related]
7. Targeting the B cell in vasculitis.
Walsh M; Jayne D
Pediatr Nephrol; 2009 Jul; 24(7):1267-75. PubMed ID: 18931860
[TBL] [Abstract][Full Text] [Related]
8. B cell depletion in autoimmune disease.
Gorman C; Leandro M; Isenberg D
Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S17-21. PubMed ID: 15180893
[TBL] [Abstract][Full Text] [Related]
9. B-cell targeted therapies in human autoimmune diseases: an updated perspective.
Townsend MJ; Monroe JG; Chan AC
Immunol Rev; 2010 Sep; 237(1):264-83. PubMed ID: 20727041
[TBL] [Abstract][Full Text] [Related]
10. B-cell depletion and repopulation in autoimmune diseases.
Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
[TBL] [Abstract][Full Text] [Related]
11. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
12. B-cell-directed therapy for inflammatory skin diseases.
Nagel A; Hertl M; Eming R
J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
[TBL] [Abstract][Full Text] [Related]
13. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
Perosa F; Prete M; Racanelli V; Dammacco F
J Intern Med; 2010 Mar; 267(3):260-77. PubMed ID: 20201920
[TBL] [Abstract][Full Text] [Related]
14. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application.
Mease PJ
J Rheumatol; 2008 Jul; 35(7):1245-55. PubMed ID: 18609733
[TBL] [Abstract][Full Text] [Related]
15. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
16. [B-cell-targeted therapy in the treatment of autoimmune diseases].
Roll P; Tony HP
Z Rheumatol; 2009 May; 68(3):255-9. PubMed ID: 19384549
[TBL] [Abstract][Full Text] [Related]
17. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.
Musette P; Bouaziz JD
Front Immunol; 2018; 9():622. PubMed ID: 29706952
[TBL] [Abstract][Full Text] [Related]
18. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Ann Rheum Dis; 2007 May; 66(5):700-3. PubMed ID: 17040963
[TBL] [Abstract][Full Text] [Related]
19. Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin.
Ly S; Nedosekin D; Wong HK
Am J Clin Dermatol; 2023 Mar; 24(2):247-273. PubMed ID: 36630066
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in systemic lupus erythematosus].
Terrier B; Mouthon L
Med Sci (Paris); 2013 Jan; 29(1):65-73. PubMed ID: 23351696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
